Lynch TJ - Search Results

1

Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.

Zhai R, Liu G, Zhou W, Su L, Heist RS, Lynch TJ, Wain JC, Asomaning K, Lin X, Christiani DC. Zhai R, et al. Among authors: lynch tj. Clin Cancer Res. 2008 Jan 15;14(2):612-7. doi: 10.1158/1078-0432.CCR-07-1655. Clin Cancer Res. 2008. PMID: 18223238

2

Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.

Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. Xu LL, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1555-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496043

3

Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692111

4

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Clin Cancer Res. 2004 Aug 1;10(15):4939-43. doi: 10.1158/1078-0432.CCR-04-0247. Clin Cancer Res. 2004. PMID: 15297394

5

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: lynch tj. Cancer Lett. 2004 Oct 8;214(1):69-79. doi: 10.1016/j.canlet.2004.06.027. Cancer Lett. 2004. PMID: 15331175

6

The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.

Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: lynch tj. Cancer. 2004 Dec 15;101(12):2802-8. doi: 10.1002/cncr.20716. Cancer. 2004. PMID: 15534883 Free article.

7

Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.

Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):491-6. doi: 10.1158/1055-9965.EPI-04-0612. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734977

8

Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.

Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, Lynch TJ, Wain JC, Neuberg D, Liu G, Christiani DC. Suk R, et al. Among authors: lynch tj. Clin Cancer Res. 2005 Feb 15;11(4):1534-8. doi: 10.1158/1078-0432.CCR-04-1953. Clin Cancer Res. 2005. PMID: 15746057

9

Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.

Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):567-70. doi: 10.1158/1055-9965.EPI-04-0482. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767330

10

Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients.

Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Giovannucci E, Christiani DC. Zhou W, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2303-9. doi: 10.1158/1055-9965.EPI-05-0335. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16214909 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters